New respiratory diseases in personnel deployed to Southwest Asia after September 11th raise major concerns about the impacts of airborne particulate matter. Although regulations exist, the knowledge about how particulates influence disease states is limited, precluding the appropriate recognition, prevention and treatment of deployment-related lung diseases. We applied two genomics assays, Precision Run-on sequencing (PRO-seq) and the assay for transposase accessible chromatin with sequencing (ATAC-seq), to characterize the small airway epithelial cell response to Afghan desert particulate matter (APM). In addition to cellular pathways that regulate susceptibility to further insults, such as cytochrome P450 or P53, we identified novel pathways associated with APM exposure, such as GRHL2 loss or TEAD3 activation. We further demonstrated that TEAD3 activation was unique to APM exposure despite similar inflammatory responses when compared with wood smoke particle (WSP) exposure. Our results establish the utility of an integrated genomics approach in characterizing responses to exposures and identify cellular and genomic targets for advanced investigation of the pathogenesis of deployment-related respiratory disease.